HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Algorithm for antinuclear antibodies in subjects with clinical suspicion of autoimmune diseases.

AbstractOBJECTIVES:
Antinuclear antibodies (ANA) are fundamental in the diagnosis of systemic autoimmune rheumatic diseases (SARDs). Different assays for ANA screening are available, such as indirect immunofluorescence (IIF) on HEp-2 cells and Multiplex fluorescent immunoassay (MFI). This study aimed to clarify the importance of ANA detected only by IIF in the future development of SARDs and to recommend a laboratory algorithm that integrates the available diagnostic approaches to optimise the diagnosis of ANA IIF+MFI- subjects.
METHODS:
A total of 9,291 subjects with clinical suspicion of SARDs were evaluated for ANA by IIF and MFI. One hundred and ninety-eight subjects (2.1%) were ANA IIF+MFI-, who were followed up for 2 years. ANA were evaluated using IIF on HEp-2 cells and MFI on the BioPlex 2200.
RESULTS:
The ANA IIF+MFI- cohort included 106 subjects with SARDs, 26 subject with other autoimmune diseases (not-SARDs) and 66 subjects with minor symptoms or ANA requested in check-ups. Only 94 subjects underwent re-evaluation. After a 2-year follow-up, most re-evaluated subjects (51 patients) became ANA negative for both assays (mainly rheumatoid arthritis, polymyalgia and inflammatory bowel disease patients) and 35 subjects remained ANA IIF+MFI- (principally systemic sclerosis and systemic lupus erythematosus patients). A new algorithm for ANA evaluation was suggested.
CONCLUSIONS:
According to the proposed algorithm, ANA IIF+MFI- subjects should be screened by an alternative solid-phase assay such as line-immunoassay or ELISA.
AuthorsLaura Naranjo, Ora Shovman, Dolores Pérez, María Infantino, Oscar Cabrera-Marante, Fernando Lozano, Boris Gilburd, Mariangela Manfredi, Manuel Serrano, Luis Morillas, Yehuda Shoenfeld, Antonio Serrano
JournalClinical and experimental rheumatology (Clin Exp Rheumatol) 2020 Jul-Aug Vol. 38 Issue 4 Pg. 633-639 ISSN: 0392-856X [Print] Italy
PMID31694754 (Publication Type: Journal Article)
Chemical References
  • Antibodies, Antinuclear
Topics
  • Algorithms
  • Antibodies, Antinuclear
  • Autoimmune Diseases
  • Fluorescent Antibody Technique, Indirect
  • Humans
  • Lupus Erythematosus, Systemic

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: